Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is focused on helping athletes with a common hip condition called femoroacetabular impingement (FAI) syndrome. FAI syndrome occurs when abnormal bone shapes around the hip joint cause friction during movement, leading to pain, reduced performance, and, over time, more serious injury. While this issue is well-studied in male professional athletes, little is known about how it affects female and collegiate athletes, or how to prevent it from worsening.
In this study, athletes diagnosed with FAI syndrome will participate in a 12-week in-season exercise program designed to reduce pain, improve hip strength and movement, and help prevent further injury-all while continuing their regular sports training.
Participants will be randomly assigned to either:
At the end of the study, the control group will have the option to access the exercise program.
The study will track changes in pain, physical performance, injury recurrence, and athlete satisfaction with the program. This research aims to improve how we manage hip injuries in athletes and help keep them active during the competitive season.
Study Rationale Femoroacetabular impingement (FAI) syndrome is a common source of hip pain in athletes participating in cutting, pivoting, and high-impact sports such as soccer, basketball, ice hockey, and ringette. It is characterized by abnormal contact between the femoral head and acetabulum, which may lead to cartilage damage, labral tears, and early osteoarthritis. While research has primarily focused on male professional athletes, there is limited evidence regarding the early management of FAI in younger, female, and collegiate athletes.
Current management strategies often emphasize post-season rehabilitation or surgical interventions, limiting opportunities to explore conservative strategies that allow continued play during the competitive season. This randomized controlled trial (RCT) addresses that gap by evaluating a novel, in-season, 12-week exercise intervention designed to mitigate symptoms, maintain sport participation, and potentially delay or reduce long-term structural damage.
Study Objectives
Study Design Participants diagnosed with FAI syndrome based on clinical evaluation and symptom history will be randomized to either the intervention or a time-and-attention control group. The intervention group will complete a structured neuromuscular and hip-specific rehabilitation program, while the control group receives educational support and a progressive mobility and recovery (PMR) option during the same 12-week period. Randomization ensures balanced comparison of feasibility and clinical endpoints.
Intervention Protocol
The 12-week intervention focuses on:
Participants complete the exercises a minimum of 3 times/week, and will be trained at the start of each phase in-person or remotely by a trained clinician. Exercise progression will occur after 4 weeks per phase. Compliance is monitored through weekly questionnaires.
Control Group Protocol: Time and Attention Control + PMR Option The control group will not participate in the structured exercise program but will receive supportive follow-up and access to a three-phase progressive muscle relaxation (PMR) program (audio guided). This design ensures time and engagement are balanced across groups.
The control group protocol includes:
While participation in the PMR component is optional, it offers a low-intensity, restorative alternative without introducing strength training or neuromuscular drills that may overlap with the primary intervention. Control group participants are also offered the full exercise protocol following study completion.
Significance
This is one of the first studies to investigate an in-season, non-operative intervention for FAI syndrome in athletes during competitive play. It targets a high-risk group (female and collegiate athletes), with potential to:
Feasibility findings will guide future larger-scale studies, including refined criteria for participant selection, adherence support, and integration within team-based medical models.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exercise Intervention | Experimental | Participants in the experimental arm will complete a 12-week, in-season progressive exercise program designed to improve hip strength, motor control, and function. Participants will complete a training session with a study trained clinician prior to beginning each respective phase of the program, either in person, or virtually per the participant preference. Participants will have the option to complete the intervention following a guided video for each phase, or on their own, at a location of their choosing, a minimum of three times per week. |
|
| Time and Attention Control | Sham Comparator | Participants in the control arm will complete a 12-week, three-phase progressive muscle relaxation (PMR) program, adapted from the Jacobson method. Participants will complete a training session with a study trained clinician prior to beginning each respective phase of the program, either in person, or virtually per the participant preference. Participants will have the option to complete the intervention following a guided audio for each phase, at a location of their choosing, a minimum of three times per week. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Progressive Hip Strengthening Program | Other | This 12-week, in-season exercise intervention is designed for athletes with FAI syndrome and consists of three progressive phases. Phase 1 (Weeks 1-4): Focus on neuromuscular re-education and motor control using low-load exercises to improve hip and core activation, alignment, and stability. Phase 2 (Weeks 5-8): Targeted strengthening with increased load and movement complexity, emphasizing single-leg control, endurance, and pelvic stability. Phase 3 (Weeks 9-12): Integration of dynamic control, proprioception, and sport-specific movement patterns to support return to performance. Exercises target gluteus medius, gluteus maximus, core musculature, and functional movement systems. Participants complete the program >=3 times per week. Weekly questionnaires will monitor symptoms, adherence, and other management (e.g., physiotherapy). |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of Agreement to Screening | the number of participants whom agree to be screened/the number of participants approached for recruitment | up to 9 months - study time frame is 12 months, with the last participant able to enroll at month 9 to allow for 12 weeks of intervention |
| Eligibility Proportion | the number screened positive for inclusion (evidence of FAI syndrome)/number of participants who agreed to be screened (consented) | up to 9 months - study time frame is 12 months, with the last participant able to enroll at month 9 to allow for 12 weeks of intervention |
| Consent Proportion | Number of participants screened positive and agreed to participate in intervention/number screened positive for inclusion | up to 9 months - study time frame is 12 months, with the last participant able to enroll at month 9 to allow for 12 weeks of intervention |
| Randomization Proportion | The number of participants randomized/the number of participants screened positive and agreed to participate | up to 9 months - study time frame is 12 months, with the last participant able to enroll at month 9 to allow for 12 weeks of intervention |
| Trial-Arm Selection Proportion | The number agreed to each trial arm after randomization/the number of participants randomized | up to 9 months - study time frame is 12 months, with the last participant able to enroll at month 9 to allow for 12 weeks of intervention |
| Attrition Proportion | The number of participants who drop out of study/number of participants randomized in each arm |
| Measure | Description | Time Frame |
|---|---|---|
| International Hip Outcome Tool (iHOT-33) | The International Hip Outcome Tool (iHOT-33) is a 33-item patient-reported outcome measure designed to assess the health-related quality of life for young, active individuals with hip disorders. It focuses on how hip problems impact their daily activities, sports, work, and overall well-being. The iHOT-33 is a valuable tool for initial assessments, post-operative follow-ups, and clinical studies related to hip conditions. |
Not provided
Inclusion Criteria:
If participants meet the above criteria, can be screened:
- completed bilateral hip screen, including imaging, and identified as having FAI syndrome with no degenerative joint changes (if meet the remaining criteria,
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Maitland Martin, MSc, CAT(C), ATC | Contact | 403-220-5332 | hockeyhip@ucalgary.ca |
| Name | Affiliation | Role |
|---|---|---|
| Carolyn Emery, PT, PhD | Sport Injury Prevention Research Centre, Chair | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D057925 | Femoracetabular Impingement |
| ID | Term |
|---|---|
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D001326 | Autogenic Training |
| ID | Term |
|---|---|
| D006990 | Hypnosis |
| D026441 | Mind-Body Therapies |
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Progressive Muscle Relaxation | Other | Participants in the time and attention control group will complete a 12-week, three-phase progressive muscle relaxation (PMR) program based on the Jacobson method. Phase 1 introduces isolated muscle tensing and relaxing to build awareness of muscle tension and promote body-mind connection. Phase 2 focuses on sequential relaxation of muscle groups, enhancing control and reducing stress. Phase 3 transitions to full-body relaxation through guided breathing and visualization techniques. Sessions are practiced 2-3 times per week using audio guides, with weekly check-ins from study staff. Symptom response, adherence, and participant experience are tracked throughout the season. |
|
| up to 9 months - study time frame is 12 months, with the last participant able to enroll at month 9 to allow for 12 weeks of intervention |
| 12 weeks |
| Copenhagen Hip and Groin Outcome Tool (HAGOS) | Patient-reported questionnaire designed to assess the impact of hip and/or groin problems on physical function and quality of life in young to middle-aged, physically active individuals. | 12 weeks |
| Make (Isometric) Strength Testing of the Hip | Strength measures in the hip (N/kg) performed in flexion, abduction, adduction. Measures will be performed pre and post intervention. | 12 weeks |
| Passive Range of Motion | Range of motion in degrees at the hip joint in flexion, internal rotation, abduction. Performed pre and post intervention. | 12 weeks |
| Special Test Findings | Positive or negative findings on special tests in the hip which reproduce the pain of an injury (out of a maximum of 3). Performed pre and post intervention. | 12 weeks |
| D011613 |
| Psychotherapy |
| D004191 | Behavioral Disciplines and Activities |